US Politics
Trump's Obesity Drug Deal: A Step Toward Healthcare Accessibility With Caveats
President Donald Trump announced a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for obesity drugs Zepbound and Wegovy, starting with Medicare patients next year. This crucial step toward affordable healthcare demonstrates how policy can directly improve millions of lives, though we must remain vigilant against pharmaceutical profiteering.
